Discover 82 paid clinical trials in Tallahassee, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 82
FeaturedActive & Responsive
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: 35 recruiting locations
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & Responsive
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
for
Relapsing Multiple Sclerosis (RMS)
Location: 61 recruiting locations
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06869785
Phase3, Recruiting
Active & Responsive
Esprit BTK Post-Approval Study
for
Chronic Limb-Threatening Ischemia
Location: 28 recruiting locations
Sponsor: Abbott Medical Devices
Sex: All
Age: 18+
Code: NCT06656364
Recruiting
Active & Responsive
Effect of Peanut Butter on Gut and Metabolic Health
for
Dysbiosis
Location: 1 recruiting location
Sponsor: Florida State University
Sex: All
Age: 6 - 13
Code: NCT06916936
Recruiting
Active & Responsive
Inspiratory Muscle Strength Training in Adults With Obesity
for
Obesity
Location: 1 recruiting location
Sponsor: Florida State University
Sex: All
Age: 18 - 45
Code: NCT05459636
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Heart Math Resilience Program on Jail Staff
for
Stress
Location: 1 recruiting location
Sponsor: Florida State University
Sex: All
Age: 18+
Code: NCT06928610
Recruiting
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for
Chronic Granulomatous Disease (CGD)
Location: 50 recruiting locations
Sponsor: Ensoma
Sex: All
Age: 0+
Code: NCT06605378
Recruiting
Active & Responsive
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
for
Advanced Non-Small Cell Lung Cancer,
Location: 76 recruiting locations
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT04613596
Phase2, Phase3, Recruiting
Active & Responsive
A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma